Harsch Mutya 4

What Happened
Mutya Harsch, Chief Legal Officer and General Counsel of VYNE Therapeutics (VYNE), had 3,464 shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. The withholding price was $0.65 per share, representing a disposal value of $2,254. This is a tax-withholding disposition (routine) rather than an open-market sale.

Key Details

• Transaction date: 2026-06-30; filing date: 2026-07-02 (appears timely; Form 4 typically due within two business days).
• Shares withheld/disposed: 3,464 at $0.65 per share; total value reported $2,254.
• Transaction code: F (payment of exercise price or tax liability).
• Footnote: F1 — shares were withheld by the issuer to satisfy tax withholding on RSU vesting.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context
This was a cashless tax-withholding event tied to RSU vesting, a routine administrative disposition that does not necessarily signal insider sentiment. For retail investors, purchases are generally more informative than withholding disposals; this filing reflects tax-related mechanics rather than an intentional open-market sale.